a b s t r a c t GATA transcription factors regulate an array of genes important in cell proliferation and differentiation. Here we report the identification of regulator of G protein signaling 4 (RGS4) as a novel target for GATA-6 transcription factor. Although three sites (a, b, c) within the proximal region of rabbit RGS4 promoter for GATA transcription factors were predicted by bioinformatics analysis, only GATA-a site (16 bp from the core TATA box) is essential for RGS4 transcriptional regulation. RT-PCR analysis demonstrated that only GATA-6 was highly expressed in rabbit colonic smooth muscle cells but GATA-4/6 were expressed in cardiac myocytes and GATA-1/2/3 expressed in blood cells. Adenovirus-mediated expression of GATA-6 but not GATA-1 significantly increased the constitutive and IL-1b-induced mRNA expression of the endogenous RGS4 in colonic smooth muscle cells. IL-1b stimulation induced GATA-6 nuclear translocation and increased GATA-6 binding to RGS4 promoter. These data suggest that GATA factor could affect G protein signaling through regulating RGS4 expression, and GATA signaling may develop as a future therapeutic target for RGS4-related diseases.
Introduction
The GATA family of the transcription factors were named because of their direct binding to the consensus DNA sequence (T/ A)GATA(A/G) within the promoters and enhancers of target genes. They are evolutionarily conserved. In vertebrates, six members of the GATA family have been identified. GATA-1, -2 and -3 are mainly associated with haematopoiesis, whereas GATA-4, -5 and -6 are involved in cardiogenesis, neurogenesis and gut development [1e3] . GATA transcription factors play important roles in the proliferation and differentiation of various cell types including smooth muscle cells (SMCs) [4, 5] . The cardiomyocytes express GATA-4 and GATA-6, whereas vascular SMCs express only GATA-6. GATA-6 plays a critical role in maintaining the contractile phenotype of vascular SMCs [4, 6] . For example, overexpression of GATA-6 activates the transcription of several contractile proteins and leads to cell cycle arrest in cultured vascular SMCs [6] . GATA-6 expression and its DNA-binding activity are reduced in neointimal vascular SMCs after rat carotid artery injury, while overexpression of GATA-6 limits the neointimal proliferative response [7] . However, SMC-specific GATA-6 knockout or dominant-negative GATA-6 mutant inhibition leads to little or no change in expression of genes encoding contractile proteins in vascular SMCs [6] . Earlier studies demonstrated that GATA-6 was not expressed in visceral SMCs populating the gastrointestinal tract and uterus, while it was expressed in the epithelial cells of the gastrointestinal tract [8] . Later study using immunohistochemistry showed that GATA-6 is expressed in the gut [9] . A recent study showed that GATA-6 is expressed in human bladder SMCs [10] . GATA-6 regulates CPI-17 expression and Ca 2þ sensitization in bladder smooth muscles [5, 11] .
Regulator of G protein signaling (RGS) proteins are a large family of highly diverse, multifunctional signaling proteins. RGS proteins bind to the activated Ga subunit and terminates G protein signaling by boosting the intrinsic GTPase activity of Ga subunit. RGS4 is one of seven members of a classic R4 RGS protein that accelerates the GTPase activity of the Gai/o and Gaq/11 family members [12, 13] . Extensive studies have demonstrated that RGS4 plays an important role in regulating smooth muscle contraction, cardiomyocyte development, neural plasticity and psychiatric disorders [14, 15] . However, the regulatory mechanisms underlying RGS4 expression and function remain largely unclear. We have recently shown that the pro-inflammatory cytokine, interleukin-1b (IL-1b) induces upregulation of RGS4 mRNA and protein expression in rabbit colonic SMCs [16] . The increase in RGS4 expression is responsible for IL-1b-induced inhibition of initial Ca 2þ -dependent smooth muscle contraction [16] . Up-regulation of RGS4 expression by IL-1b is mediated by the canonical IKK2/IkBa/NFkB signaling [17] , enhanced by extracellular signal-regulated kinases (ERK1/2) and p38 mitogen-activated protein (MAP) kinase [18] , and inhibited by phosphoinositide-3 kinase [18] and JNK pathway [19] .
To understand the transcriptional mechanism of RGS4 expression, we have cloned rabbit RGS4 promoter [20] and found that several transcription factors regulate RGS4 promoter activity [17e20]. Sequence analysis predicts three sites for GATA transcription factors within the proximal region [20] . In the present study, we characterized the expression pattern of GATA transcription factors in the colonic SMCs and investigated the role of GATA-6 in regulating RGS4 transcription.
Material and methods

Reagents, antibodies and adenovirus
IL-1b was obtained from Alexis Biochemicals (San Diego, CA). JNK-II inhibitor (SP600125, Anthra [1,9-cd]pyrazol-6(2H)-one, 1,9-pyrazoloanthrone), and IKK2-IV (IKK2 inhibitor IV, [5-(p-Fluorophenyl)-2-ureido]thiophene-3-carboxamide) were obtained from EMD Chemicals (San Diego, CA) and dissolved in dimethyl sulfoxide (DMSO). Antibodies against GATA-1, GATA-6, GAPDH and b-actin were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Affinity-purified anti-Rgs4 antibody was kindly provided by Dr. Susanne M. Mumby (University of Texas Southwest Medical Center). Adenovirus (Ad) encoding EGFP, GATA-1 and GATA-6 were obtained from Vector Biolabs (Philadelphia, PA). All the other reagents were from Sigma (St. Louis, MO).
SMC culture
New Zealand White rabbit (2e2.5 kg, male) was used following IACUC guidance at Temple University. After euthanization with overdose of euthasol (150 mg/kg, i.v.), the distal colon was removed and placed in HEPES-buffered smooth muscle media. The circular SMCs were cultured as previously described [16, 17, 21] .
Deletion and site-directed mutagenesis
The wild-type RGS4 promoter (designed as RGS4-P1) was generated by PCR cloning as described previously [20] . Various deletion constructs of pMluc3-RGS4-P1 (À1389 to þ50) were generated through digestion, blunting and ligation by analyzing and combining the digestion sites within the insert and the backbone vector. The mutants pMluc3-RGS4-P2(-962 to þ50) and pMluc-RGS4-P3(-1389 to À816) were generated by single digestion with PstI and HindIII respectively followed by ligation. The mutant pMluc-RGS4-P4(-247 to þ50) was generated by double digestion with XhoI/XbaI followed by blunting and ligation.
Potential GATA transcription factor binding sites within RGS4 promoter were identified by MatInspector (http://www.genomatix. de) and TFSEARCH (http://www.cbrc.jp). Mutation of the binding site for the GATA transcription factors in the reporter vector was performed by site-directed mutagenesis using the QuikChange kit (Stratagene). Mutagenic primers as shown in Table 1 led to nucleotide change in entire binding site for transcriptional factor.
Cell transfection, luciferase reporter assays, electrophoretic mobility shift assay, chromatin immunoprecipitation assay, degenerative RT-PCR and RT-qPCR, Western blot, immunocytochemistry and statistical analysis. All these methods were performed as we previously described [16e21].
Results
GATA factor is critical for RGS4 promoter activity
When performing deletion studies on the RGS4 P1 promoter activity using luciferase reporter assay, we identified a proximal promoter region (À247, P4) with a "maximal" promoter activity [20] . Further deletion studies identified the most proximal region (À75, P5) with higher promoter activity ( Fig. 1A and B) . The P5 contains the conserved typical TATA box (À35) that may serve as core promoter and a sole binding site for transcription factor GATA (À51). Site-directed mutation of this GATA binding site (designated GATA-a) in P5, P4 and P2 dramatically reduced the promoter activity as compared with corresponding wild-type promoter region (Fig. 1B) . These data suggest that the GATA-a response element is critical for RGS4 promoter activity and the binding GATA factor may serve as a trans-activator for RGS4 transcription.
The bioinformatics analysis of the cloned P1 promoter sequence identified two additional potential cis-elements for GATA transcription factor designated GATA-b and -c (Fig. 1A) . Removal of the regions that contain these two additional GATA sites (GATA-b and -c) plus other transcription factor sites led to the increase of RGS4 promoter activity from 21-fold (P2) or 28-fold (P4) to 82-fold (P5) (Fig. 1B) , suggesting that these two additional GATA sites plus other factors may suppress the core promoter activity. To clarify the role of GATA sites and other factors, we chose P4 as a model system because P4 containing AP1, NFkB and GATA-a/b sites (Fig. 1A) . As shown in Fig. 1C , mutation of NFkB binding site inhibited while mutation of AP1 binding site enhanced the promoter activity of P4, consistent with our previous observation that NFkB signaling stimulates while AP1 signaling represses the transcription of RGS4 [17, 19, 20] . Dual deletion of NFkB and AP1 sites induced a mixed effect on the P4 promoter activity. Again, mutation of GATA-a site in corresponding promoters all reduced the promoter activity, confirming the critical role of GATA-a site as a main trans-activator on RGS4 core promoter.
GATA-a site is highly conserved and contributes to RGS4 promoter activity
Homology analysis of predicted RGS4 promoter from different species showed that only GATA-a site (TCTGATTGGCT) shares 100% identity ( Fig. 2A) . To further confirm the binding activity of the conserved GATA-a site with GATA transcription factors, we performed EMSA using biotinylated (Fig. 2B) or radiolabeled ( Fig. 2C and D) oligonucleotide probe containing GATA-a motif. The GATA-a DNA-binding complexes were detectable in nuclear extracts from human Hela cells (Fig. 2B and C) and rabbit colonic SMCs (Fig. 2D) . The specific binding band of the shifted protein-DNA complex was completely blocked by pretreatment with 20-200x unlabeled GATA-a probe. The specificity of GATA-a binding to GATA-6 but not GATA-1 transcription factor was confirmed by pretreatment with anti-GATA antibody ( Fig. 2C and D) . The GATA-a binding of the endogenous GATA-6 was corroborated with CHIP-PCR analysis (Fig. 2E) . These data suggest that GATA-a site near the core promoter (16 bp from the highly conserved TATA box) is functional in recruiting GATA-6 transcription factor to activate RGS4 transcription.
GATA-6 is highly expressed in rabbit colonic SMCs
Vascular SMCs express only GATA-6 [8] . Previous report using in situ hybridization technique showed the absence of all identified GATA members in mouse gut SMCs [8] . However, immunohistochemical studies demonstrated the presence of GATA-6 in mouse gut SMCs [9] . To determine whether GATA members are expressed in rabbit gut SMCs, we screened the expression pattern of all the family members by performing degenerative RT-PCR using cultured pure SMCs from rabbit colon. The rabbit cardiomyocytes and blood cells were used as positive control for various members of GATA family. Only GATA-6 is highly expressed in colonic SMCs, while GATA-2 is expressed at a lower level (Fig. 3A) . The cardiomyocytes expressed GATA-4 and -6 while the blood cells expressed mainly GATA-1 to À3, consistent with previous reports [22, 23] . The expression of GATA-6 but not GATA-1 in rabbit colonic SMCs was further corroborated at the protein level by Western blot analysis ( Fig. 3B and C) . The efficiency of GATA-1 antibody was verified using the enteric neuronal cell line (Fig. 3B). 3.4. Overexpression of GATA-6 but not GATA-1 increases endogenous RGS4 expression at both mRNA and protein levels in rabbit colonic SMCs
The presence of GATA-6 in SMCs and cardiomyocytes contributes to its function in changing the phenotypes of these cells. As described above, GATA-6 in SMCs binds to the promoter of RGS4 both in vitro and in vivo (Fig. 2BeE) . To provide a direct evidence that GATA-6 specifically regulates RGS4 expression, we employed adenovirus-mediated gene delivery system to overexpress GATA-6 in rabbit SMCs and performed RT-qPCR and Western blot analysis. Ad-EGFP virus at 10 MOI achieved over 95% transduction efficiency in rabbit colonic SMCs (Fig. 4A) . Overexpression of GATA-6, validated by RT-PCR (Fig. 4B) , significantly increased RGS4 transcription (Fig. 4C) . In addition, GATA-6 significantly enhanced IL-1b-induced upregulation of RGS4 mRNA and protein expression (Fig. 4C and D) . However, overexpression of GATA-1 had no significant effect on the constitutive and IL-1b-induced expression of RGS4 mRNA and protein ( Fig. 4C  and D) , though it moderately inhibited mRNA expression of endogenous GATA-6 (Fig. 4B) . These results suggest that GATA-6 expression in SMCs plays an important role in maintaining RGS4 expression in SMCs while GATA-1 is indispensable for RGS4 expression in SMCs.
IL-1b stimulation induced GATA-6 nuclear translocation and RGS4 promoter-binding activity
To assess if GATA-6 undergoes nuclear translocation after IL-1b stimulation, we performed immunocytochemistry with GATA-6 antibody at different time point after IL-1b treatment in cultured colonic SMCs. Under physiological condition, GATA-6 was present in the cytoplasm of colonic SMCs. Upon IL-1b stimulation, GATA-6 translocated into nucleus within minutes and recovered partially to cytoplasm at 1 h (Fig. 5A) . Treatment for 1 h with IL-1b but not IL-17A increased the binding of GATA-6 to the RGS4 promoter while FGFb reduced GATA-6 binding to RGS4 promoter (Figs. 2C and 5B). To determine the potential effect of IL- Table 1 Sequences for PCR primers, site-mutagenesis oligonucleotides.
Note: The wild-type GATA site highlighted red color but the mutant GATA sites highlighted green color. The overhang tcga on the 5'-end of the probe was used for end-labeling. 1b-stimulated signaling pathways on the RGS4 GATA-a binding activity, we treated the cultured rabbit SMCs with IL-1b in the presence or absence of JNK inhibitor (for AP1 pathway) and IKK2 inhibitor (for NFkB pathway). IL-1b-induced GATA-6 binding to RGS4 promoter was blocked by pretreatment with IKK2 inhibitor but not JNK inhibitor (Fig. 5C ). These data suggest that IL-1b-stimulated activation of IKK2/NFkB signaling modulates GATA-6-mediated RGS4 upregulation in SMCs. promoter vector carrying renilla luciferase and pGL4-CMV vector carrying firefly luciferase (for normalization). After 24 h, the renilla and firefly luciferases were measured separately. The relative fold changes in renilla luciferase activity after normalization by firefly luciferase were expressed as compared with the empty vector. Data represents the mean ± SEM of 3e4 independent experiments. **P < 0.01 indicate statistically significant increase by student's t-test compared with corresponding P1 (B) or P4 (C). þþ p < 0.01 indicates significant decrease in GATA-a mutants as compared with corresponding GATA-a non-mutants. 
Discussion
The salient finding in the present study is the identification of RGS4 as a novel target gene for the GATA family of transcription factors. The GATA family executes its functions via regulating the transcription of its target genes. GATA-6 regulates a large array of target genes related to muscle cell differentiation [4e6,10,23e29]. For SMC contraction, GATA-6 upregulates contractile proteins [4e6] and caveolin [6, 24, 30] . In the present study, we demonstrated for the first time that GATA-6 is involved in G protein signaling and acts as a critical activator for the transcriptional expression of RGS4. Gut SMC contractility is composed of initial and sustained phases. Our previous studies demonstrated that RGS4 and CPI-17 mediate the initial and sustained contraction of gut SMCs respectively [16, 31] . Upregulation of RGS4 mediates the inhibition of initial contraction induced by IL-1b [16] or colonic inflammation [32] . GATA-6 is highly expressed in gut SMCs, suggesting that GATA-6 may regulate the smooth muscle contraction via affecting RGS4 and perhaps other key targets mediating initial and sustained contraction of gut smooth muscles. For example, GATA-6 upregulates CPI-17 expression in bladder SMCs and thus promotes PKC-mediated signaling and bladder smooth muscle remodeling [5, 11] . Therefore, GATA-6 signaling pathway may be a novel therapeutic target for modulating SMC contractility.
The conserved DNA motif that binds to GATA transcription factor was initially identified in the globin promoter from erythroid cells [33] . Later on, similar GATA motifs have been identified in a huge list of genes important in the proliferation and differentiation of cardiomyocytes and various SMCs [4e6, 10,23e29,34] . The family of GATA transcription factors contains 6 members with different pattern of cellular and tissue expression. GATA-6 is expressed during embryogenesis as early as the blastocyst stage at 3.5 days. Mouse GATA-6 knockout is lethal at 5.5 days postcoitum due to a defect in extraembryonic tissue formation [35] . GATA-6 is expressed mainly in heart, muscle, epithelium and all types of smooth muscles in the gastrointestinal tract, respiratory tract, arteries, and urogenital tract [4e6,10,23e29,36e39]. In gastrointestinal tract, previous studies have demonstrated extensive . In GATA-6-deficient mice, there are dramatic impairments in the proliferation, migration and lineage maturation of colonic epithelium [40] . However, the expression and function of GATA-6 in gut SMCs remain controversial [8, 9] . We provide convincing evidence that GATA-6 is highly expressed in colonic SMCs and overexpression of GATA-6 but not GATA-1 enhances IL-1b-induced upregulation of RGS4. Such unique expression may contribute to the important role of GATA-6 in regulating gut SMC function. GATA-6 has been shown to maintain the differentiated state of vascular SMCs [41] , likely via regulation of contractile protein expression [4] . In gut SMCs, GATA-6 may play a similar role in regulating muscle contractile proteins and cell differentiation. Within the identified promoter region of rabbit RGS4, there are three sites for GATA factors. Only GATA-a site is highly conserved among different species. Deletion and site-mutagenesis assay validated the essential role of GATA-a site in regulating RGS4 promotor activity. However, the role of GATA-b and GATA-c remains to be determined because they are neighboring with several sites for additional transcription factors such as NFkB, AP1 and HSF, and thus may modulate the coordination of these transcription factors.
In conclusion, we demonstrated that the high level of GATA-6 expression in gut SMCs plays an essential role in regulating the expression of RGS4 via GATA-a cis-element. GATA-6 may act as a novel positive regulator for RGS4 and thus contributes to RGS4-related cellular process and diseases. promoter. SMCs were pretreated with JNK inhibitor II (10 mM) or IKK2 inhibitor IV (1 mM) for 30 min before IL-1b (10 ng/ml) treatment for 1 h. Electrophoretic mobility shift assay of whole cell lysates with radio-labeled GATA-a wildtype probe was performed.
